Companies Dominating the Neurology Devices Landscape
- Eli Lilly and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- LivaNova PLC
- Medtronic Plc
- Abbot Laboratories
- Magstim Co Ltd.
- Pear Therapeutics, Inc.
- Penumbra, Inc.
- Stryker Corporation
- Boston Scientific Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of neurology devices is estimated at USD 16.55 billion.
Neurology Devices Market size was valued at USD 15.51 billion in 2024 and is likely to cross USD 41.68 billion by 2037, registering more than 7.9% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is poised to account for largest revenue share by 2037, led by increasing awareness regarding healthcare amongst people, along with improving healthcare facilities in the region.
The major players in the market are Johnson & Johnson, LivaNova PLC, Medtronic Plc, Abbot Laboratories, Magstim Co Ltd., Pear Therapeutics, Inc., Penumbra, Inc., Stryker Corporation, and others.
